Mark Andrews to Drug Design
This is a "connection" page, showing publications Mark Andrews has written about Drug Design.
Connection Strength
0.037
-
Allerton CM, Andrews MD, Blagg J, Ellis D, Evrard E, Green MP, Liu KK, McMurray G, Ralph M, Sanderson V, Ward R, Watson L. Design and synthesis of pyridazinone-based 5-HT(2C) agonists. Bioorg Med Chem Lett. 2009 Oct 01; 19(19):5791-5.
Score: 0.019
-
Fish PV, Andrews MD, Jonathan Fray M, Stobie A, Wakenhut F, Whitlock GA. 4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships. Bioorg Med Chem Lett. 2009 May 15; 19(10):2829-34.
Score: 0.018